Holen Sie sich die Stockscreener-App
47.46
0.84%
-0.40
Handel nachbörslich:
47.70
0.24
+0.51%
Schlusskurs vom Vortag:
$47.86
Offen:
$48.3
24-Stunden-Volumen:
2.48M
Relative Volume:
0.81
Marktkapitalisierung:
$6.03B
Einnahmen:
$638.78M
Nettoeinkommen (Verlust:
$-22.66M
KGV:
-272.13
EPS:
-0.1744
Netto-Cashflow:
$122.18M
1W Leistung:
+2.46%
1M Leistung:
+21.66%
6M Leistung:
+168.14%
1J Leistung:
+256.57%
1-Tages-Spanne:
$47.32
$49.19
1-Wochen-Bereich:
$45.21
$50.34
52-Wochen-Spanne:
$11.16
$50.34
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, HQY, TEM, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
47.46 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
VEEV
Veeva Systems Inc
|
213.51 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
63.02 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
104.41 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
46.70 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
80.79 | 5.81B | 646.34M | -512.40M | 202.76M | -6.6871 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | Eingeleitet | Piper Sandler | Neutral |
| 2025-02-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-10 | Eingeleitet | Barclays | Overweight |
| 2023-03-31 | Eingeleitet | Stephens | Overweight |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
| 2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-10 | Eingeleitet | Stifel | Buy |
| 2020-03-05 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
| 2019-10-07 | Eingeleitet | Cowen | Outperform |
| 2019-10-07 | Eingeleitet | JP Morgan | Overweight |
| 2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
TXG|10X Genomics Inc|Price:45.915|Chg%:-0.355 - TradingKey
10X Genomics Inc (TXG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TXG|10X Genomics Inc|Price:46.270|Chg%:-1.790 - TradingKey
10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance Australia
10x Genomics, Inc. (TXG) Interactive Stock Chart - Yahoo! Finance Canada
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - Yahoo Finance
10X Genomics2026 Funding Rounds & List of Investors - Tracxn
10X Genomics Inc (TXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
10x Genomics stock hits 52-week high at 46.35 USD By Investing.com - Investing.com South Africa
10x Genomics stock hits 52-week high at 46.35 USD - Investing.com UK
How 10x Genomics Inc. (TXG) Affects Rotational Strategy Timing - Stock Traders Daily
Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals - GlobeNewswire Inc.
10X Genomics Inc (TXG) Institutional Confidence - TradingKey
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 - BioSpace
ETFs Investing in 10x Genomics Inc Class A Stocks - TradingView
10x Genomics to report Q2 2026 results on August 6 - scanx.trade
10x Genomics sets Aug. 6 webcast to discuss second-quarter results - Stock Titan
Top 3 Health Care Stocks That May Implode This Month - Benzinga
TXG Stock Rallies As Wall Street Hikes Price Targets - StocksToTrade
10x Genomics Is Maintained at Buy by Canaccord Genuity - Moomoo
4 Best Genetic Sequencing Stocks for 2026 and How to Invest - The Motley Fool
BofA Securities Adjusts 10x Genomics Price Target to $46 From $30 - Moomoo
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% Downside - TradingView
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - MSN
10x Genomics Inc. (TXG) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Does 10x Genomics (TXG) Leaving Russell Value Indexes Reframe Its Growth Versus Profitability Story? - Yahoo Finance
TXG Stock Climbs As Wall Street Hikes Price Targets - StocksToTrade
Is 10x Genomics (TXG) Overvalued Following Its Earnings Beat? - Yahoo Finance
10x Genomics stock hits 52-week high at 40.65 USD - Investing.com
10x Genomics stock hits 52-week high at 40.65 USD By Investing.com - Investing.com India
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $32.08, Implies 14% Downside - TradingView
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) - Yahoo Finance
10x Genomics Is Maintained at Neutral by Citigroup - Moomoo
Price to sales forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
What Does 10x Genomics' (TXG) Russell Value Index Exit Reveal About Its Evolving Investor Base? - simplywall.st
1KJ Forecast — Price Target — Prediction for 2027 - TradingView
Piper Sandler raises 10X Genomics stock price target on clinical pivot - Investing.com UK
10x Genomics stock hits 52-week high at 37.58 USD - Investing.com
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000 Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (FWB:1KJ) - TradingView
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000E Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (DUS:1KJ) - TradingView
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor - Yahoo Finance
Price to earnings forward of 10x Genomics, Inc. – NASDAQ:TXG - TradingView
10x Genomics Inc Class A Actuals & Estimates (MUN:1KJ) - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x Genomics Inc Class A Actuals & Estimates (NASDAQ:TXG) - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
10 X Genomics Inc-Aktie (TXG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SULIMAN SHEHNAAZ | Director |
Jun 16 '26 |
Sale |
32.63 |
5,723 |
186,756 |
31,722 |
1.73%
1.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):